Ann: Completion of enrolment in INV102 phase II asthma study, page-3

  1. w27
    2,718 Posts.
    lightbulb Created with Sketch. 829
    The exciting part of this announcement is at the end. "We have already initiated dialogue with NIH to follow NIMA with a study in moderate to severe asthma patients, utilising our inhaled formulation." If Mitchell Glass can succeed in this it will be a real breakthrough for Invion. This is the real bonanza and if the NIH will pay for the next phase, it will relieve most of the money problems!
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
9.9¢
Change
0.003(3.13%)
Mkt cap ! $8.456M
Open High Low Value Volume
9.6¢ 9.9¢ 9.6¢ $4.743K 48.59K

Buyers (Bids)

No. Vol. Price($)
2 73355 9.6¢
 

Sellers (Offers)

Price($) Vol. No.
9.9¢ 49735 1
View Market Depth
Last trade - 15.03pm 01/08/2025 (20 minute delay) ?
IVX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.